急性心梗心肺复苏后溶栓治疗的效果观察

摘要

目的：分析急性心梗心肺复苏后采取溶栓治疗的必要性以及可行性。方法对我院2009年3月～2013年3月收治的22例急性心肌梗死患者进行研究，分成两组，治疗组12例在心肺复苏后使用尿激酶120万～200万U、链激酶150万U静注治疗或rt-PA 50 mg溶栓治疗。对照组进行常规复苏，并给予血管活性药、抗凝、抗休克和抗心律失常治疗。对两组的存活情况和治疗效果进行比较。结果治疗组急救存活率为83%，有17%死亡。对照组患者在48 h内无存活病例。两组的急救存活率比较差异具有统计学意义（P＜0.05）。结论急性心梗心肺复苏后使用溶栓治疗的效果比较好，患者的急救成功率较高。%Objective To analyze the necessity and feasibility of thrombolytic therapy for acute myocardial infarction after cardiopulmonary resuscitation. Methods22 cases of acute myocardial infarction patients were selected in our hospital from March 2009 to March 2013, they were divided into two groups, treatment group (n=12) after cardiopulmonary resuscitation used urokinase 120 million to 200 million U, streptokinase 1.5 million U static injection treatment or 50 mg RT PA thrombolytic therapy. The control group was given routine resuscitation, and the treatment of vasoactive drugs, anticoagulation, anti-shock and anti-arrhythmia were given. The survival and therapeutic effect of the two groups were compared. ResultsThe survival rate was 83% in the treatment group, 17% were died in the treatment group. Patients in the control group were not alive in the 48 h. The difference of survival rates of first aid in the two groups was statistically significant (P<0.05). Conclusion The effect of thrombolysis in acute myocardial infarction after cardiopulmonary resuscitation is good, and the success rate of ifrst aid is high.